Skip to main content
Article thumbnail
Location of Repository

Association between hormone replacement therapy and subsequent stroke: a meta analysis

By Philip M.W. Bath and Laura J. Gray
Publisher: BMJ Publishing Group
Year: 2005
OAI identifier: oai:eprints.nottingham.ac.uk:434
Provided by: Nottingham ePrints

Suggested articles

Citations

  1. A clinical trial of estrogen-replacement therapy after ischemic stroke. The New England
  2. (1967). A clinical trial of Premarin in cerebrovascular disease.
  3. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy.
  4. Bias in meta-analysis detected by a simple, graphical test.
  5. (1993). Cardiovascular health and disease in women.
  6. (2002). Clinical cardiovascular studies of hormone replacement therapy.
  7. (1998). Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet
  8. (1965). Effect of estrogen treatment in cerebrovascular diseases. Cerebral vascular diseases;
  9. Effects of estrogen plus progestin on stroke in postmenopausal women. A women's health initiative: A randomized trial.
  10. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. doi
  11. Effects of hormone replacement therapy and antioxident vitamin supplements on coronary atherosclerosis in postmenopausal women. A randomized controlled trial.
  12. Effects of hormone replacement therapy on cognitive aging and dementia risk in postmenopausal women: a review of ongoing large-scale, long-term clinical trials.
  13. (1999). Effects of progestogens on thrombosis and atherosclerosis. Human Reproduction Update
  14. (2001). Estrogen after ischemic stroke: effect of estrogen replacement on risk of recurrent stroke and death in the Women's Estrogen for Stroke Trial (WEST).
  15. Estrogen and coronary heart disease in women.
  16. Estrogen in the prevention of atherosclerosis. A randomized, double blind, placebo-controlled trial.
  17. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
  18. For the HABITS steering and data monitoring commitees. HABITS (hormonal replacement therapy after breast cancer-is it safe?), a randomised comparison: trial stopped.
  19. High-risk elderly patients prosper from cholesterol-lowering therapy (Commentary). The Lancet 2002;360:1618-1619.
  20. (2002). history and early demise - was it inevitable? Climatreric
  21. Hormone replacement therapy and stroke: risk, protection or no effect?
  22. Hormone replacement therapy in perimenopausal women and 2-year change of carotid intima-media thickness. doi
  23. (2000). Increased risk of recurrent venous thromboembolism during hormone replacement therapy. Thromb Haemost
  24. (1998). Megatrials of Hormonal Replacement Therapy.
  25. Postmenopausal hormone replacement therapy and risk of stroke. The Heart and Estrogen-progestin Replacement Study (HERS).
  26. Postmenopausal hormone replacement therapy. Scientific review.
  27. (1994). prevalence, and mortality of cardiovascular diseases.
  28. Report of the Veterans Administration Cooperative Study of Atherosclerosis. An evaluation of estrogenic substances in the treatment of cerebral vascular diseases.
  29. The ESPRIT Team. Oestrogen therapy for the prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial.
  30. The Women's Health Intiative Steering Commitee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy.
  31. The writing group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
  32. Two decades of progress in preventing vascular disease.
  33. (1965). year Indication Subjects Age (years) Female (%) Ethnicity white (%) Uterus present (%) Follow-up (years) Stroke rate (control group, %/year) Intervention (daily dose) Compliance (%) Quality score (0-5) Marmorston,

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.